Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

CureVac shares skyrocketed 35% Thursday when the biotech firm agreed to be bought by COVID-19 vaccine maker BioNTech in an all-stock deal valued at about $1.25 billion.

The Gaithersburg, Md., biotechnology company said Wednesday that results of the initial cohort of vaccines showed both the Covid-19-influenza combination and flu-vaccine candidates induced immune ...

HHS Secretary Robert F. Kennedy Jr. appointed eight new members to the Advisory Committee for Immunization Practices after ...

Scientists in India are making significant strides in protecting our beloved pets from COVID-19. The ICAR-National Veterinary ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump administration vs. mRNA vaccines ...

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

“Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory accomplishment,” Makary and Prasad wrote, “the benefit of repeat ...